Ann Dermatol.  2011 Nov;23(4):448-454.

Skin Characteristics after Fractional Photothermolysis

Affiliations
  • 1Department of Dermatology, Konkuk University School of Medicine, Seoul, Korea. 20050078@kuh.ac.kr

Abstract

BACKGROUND
Fractional photothermolysis makes thousands of minute areas called microthermal treatment zones on the skin surface and transmits thermal injury to facilitate heat shock protein formation around the dermis. Potential side effects include acneiform eruption, herpes simplex virus outbreak, erythema, and post-inflammatory hyperpigmentation.
OBJECTIVE
To investigate and compare the changes in the skin of Asian patients after two different fractional photothermolysis systems (FPS) on a split face.
METHODS
A half-split face study was performed with 10,600 nm carbon dioxide FPS on the left and 1,550 nm erbium-doped FPS on the right side of the face. Only one session of laser irradiation and several biophysical measurements were done.
RESULTS
Although both FPS proved to be effective in treating acne scar and wrinkle patients, a slightly higher satisfaction rating was seen with the 10,600 nm FPS treatment. Both types of FPS showed a significant increase in transepidermal water loss which decreased gradually after treatment and returned to pre-treatment level after 1 week. A decreased reviscometer score was sustained for a longer period in wrinkle areas treated with 10,600 nm FPS.
CONCLUSION
Even though the changes in skin varied according to different FPS wave-length, adverse outcomes, such as increased erythema and TEWL were entirely subdued within 3 months of treatment.

Keyword

Acne scar; Fractional photothermolysis; Wrinkle

MeSH Terms

Acne Vulgaris
Acneiform Eruptions
Asian Continental Ancestry Group
Carbon Dioxide
Cicatrix
Dermis
Erythema
Heat-Shock Proteins
Humans
Methylmethacrylates
Polystyrenes
Simplexvirus
Skin
Water Loss, Insensible
Carbon Dioxide
Heat-Shock Proteins
Methylmethacrylates
Polystyrenes
Water Loss, Insensible

Figure

  • Fig. 1 Acne scars on the face of a representative patient showed improvement at 3 months post-treatment (A~D: baseline, E~H: 1 day after FP treatment, I~L: 1 week after FP treatment, M~P: 3 months after FP treatment, A, B, E, F, I, J, M, N: Rt. cheek, treated with 1,550 nm FPS, C, D, G, H, K, L, O, P: Lt. cheek, treated with 10,600 nm FPS). FP: fractional photothermolysis, Rt: right, Lt: left, FPS: fractional photothermolysis system.

  • Fig. 2 In acne scar patients, 10,600 nm FPS (Lt) and 1,550 nm FPS (Rt) caused different degrees of Sebum excretion rate (A), TEWL (B), melanin index (C) and erythema index (D). Error bars represent mean±standard error of the mean. *p<0.05; †p<0.01, t test. FPS: fractional photothermolysis system, Rt: right, Lt: left, TEWL: transepidermal water loss.

  • Fig. 3 Wrinkles on the face of a patient showed improvement at 3 months post-treatment (A~D: baseline, E~H: 1 day after FP treatment, I~L: 1 week after FP treatment, M ~P: 3 months after FP treatment, A, B, E, F, I, J, M, N: Rt. cheek, treated with 1,550 nm FPS, C, D, G, H, K, L, O, P: Lt. cheek, treated with 10,600 nm FPS). FP: fractional photothermolysis, Rt: right, Lt: left, FPS: fractional photothermolysis.

  • Fig. 4 In wrinkle patients, 10,600 nm FPS (Lt) and 1,550 nm FPS (Rt) caused different degrees of reviscometer (A), TEWL (B), melanin index (C) and erythema index (D). Error bars represent mean±standard error of the mean. *p<0.05; †p<0.01, t test. FPS: fractional photothermolysis, Rt: right, Lt: left, TEWL: transepidermal water loss.


Reference

1. Yasui T, Takahashi Y, Fukushima S, Ogura Y, Yamashita T, Kuwahara T, et al. Observation of dermal collagen fiber in wrinkled skin using polarization-resolved second-harmonic-generation microscopy. Opt Express. 2009. 17:912–923.
Article
2. Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994. 19:303–308.
Article
3. Goodman GJ. Postacne scarring: a review of its pathophysiology and treatment. Dermatol Surg. 2000. 26:857–871.
Article
4. Hasegawa T, Matsukura T, Mizuno Y, Suga Y, Ogawa H, Ikeda S. Clinical trial of a laser device called fractional photothermolysis system for acne scars. J Dermatol. 2006. 33:623–627.
Article
5. Chan HH, Lam LK, Wong DS, Kono T, Trendell-Smith N. Use of 1,320 nm Nd:YAG laser for wrinkle reduction and the treatment of atrophic acne scarring in Asians. Lasers Surg Med. 2004. 34:98–103.
Article
6. Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004. 34:426–438.
Article
7. Layton AM. Optimal management of acne to prevent scarring and psychological sequelae. Am J Clin Dermatol. 2001. 2:135–141.
Article
8. Day DJ, Littler CM, Swift RW, Gottlieb S. The wrinkle severity rating scale: a validation study. Am J Clin Dermatol. 2004. 5:49–52.
9. Goodman GJ, Baron JA. The management of postacne scarring. Dermatol Surg. 2007. 33:1175–1188.
Article
10. Gomella LG, Haist SA. Pain management. Clinician's Pocket Reference. 2007. 11th ed. New York: McGraw-Hill;323–340.
11. Morgan GE, Mikhail MS, Murray MJ. Clinical anesthesiology. 2005. 4th ed. New York: McGraw-Hill;359–412.
12. Tannous Z. Fractional resurfacing. Clin Dermatol. 2007. 25:480–486.
Article
13. Hantash BM, Bedi VP, Kapadia B, Rahman Z, Jiang K, Tanner H, et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med. 2007. 39:96–107.
Article
14. Hantash BM, Bedi VP, Chan KF, Zachary CB. Ex vivo histological characterization of a novel ablative fractional resurfacing device. Lasers Surg Med. 2007. 39:87–95.
Article
15. Graber EM, Tanzi EL, Alster TS. Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatol Surg. 2008. 34:301–305.
Article
16. Setyadi HG, Jacobs AA, Markus RF. Infectious complications after nonablative fractional resurfacing treatment. Dermatol Surg. 2008. 34:1595–1598.
Article
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr